Aclarion Announces Texas Spine Care Center as New CLARITY Site
Aclarion added Texas Spine Care Center as a new clinical site for its CLARITY trial, expanding the network evaluating its Nociscan diagnostic platform. The study is a 300-patient, prospective, randomized trial designed to demonstrate Nociscan's ability to improve surgical outcomes for chronic low back pain.
Key figures
- Drug Name
- Nociscan
- Trial patients
- 300
- Interim readout
- Q4 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.